0001209191-19-050362.txt : 20190920
0001209191-19-050362.hdr.sgml : 20190920
20190920171744
ACCESSION NUMBER: 0001209191-19-050362
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190725
FILED AS OF DATE: 20190920
DATE AS OF CHANGE: 20190920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galante Joseph C
CENTRAL INDEX KEY: 0001632384
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 191105426
MAIL ADDRESS:
STREET 1: 111 TENTH AVENUE
STREET 2: SUITE 200
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-25
0
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001632384
Galante Joseph C
2525 WEST END AVENUE
SUITE 950
NASHVILLE
TN
37203
1
0
0
0
Common Stock
2019-07-25
4
P
0
60
5.87
A
13298
D
Common Stock
2019-07-26
4
P
0
60
5.86
A
13358
D
Common Stock
2019-07-29
4
P
0
60
5.87
A
13418
D
Common Stock
2019-07-30
4
P
0
60
5.83
A
13478
D
Common Stock
2019-07-31
4
P
0
60
5.94
A
13538
D
Common Stock
2019-08-02
4
P
0
120
6.15
A
13658
D
Common Stock
2019-08-05
4
P
0
60
6.17
A
13718
D
Common Stock
2019-08-07
4
P
0
60
6.07
A
13778
D
Common Stock
2019-08-09
4
P
0
120
6.02
A
13898
D
Common Stock
2019-08-12
4
P
0
60
5.91
A
13958
D
Common Stock
2019-08-13
4
P
0
60
5.78
A
14018
D
Common Stock
2019-08-14
4
P
0
60
5.49
A
14078
D
Common Stock
2019-08-16
4
P
0
120
5.62
A
14198
D
Common Stock
2019-08-19
4
P
0
60
5.51
A
14258
D
Common Stock
2019-08-20
4
P
0
60
5.43
A
14318
D
Common Stock
2019-08-21
4
P
0
60
5.49
A
14378
D
Common Stock
2019-08-22
4
P
0
60
5.31
A
14438
D
Common Stock
2019-08-23
4
P
0
60
5.38
A
14498
D
Common Stock
2019-08-27
4
P
0
120
5.19
A
14618
D
Common Stock
2019-08-29
4
P
0
120
5.04
A
14738
D
Common Stock
2019-08-30
4
P
0
60
5.14
A
14798
D
Common Stock
2019-09-04
4
P
0
60
4.79
A
14858
D
Common Stock
2019-09-06
4
P
0
120
4.91
A
14978
D
Common Stock
2019-09-09
4
P
0
60
5.19
A
15038
D
Common Stock
2019-09-10
4
P
0
60
5.38
A
15098
D
Common Stock
2019-09-11
4
P
0
60
5.02
A
15158
D
Common Stock
2019-09-13
4
P
0
120
5.18
A
15278
D
Common Stock
2019-09-16
4
P
0
60
4.97
A
15338
D
Common Stock
2019-09-18
4
P
0
120
4.93
A
15458
D
Common Stock
2019-09-19
4
P
0
60
5.21
A
15518
D
The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.
Joseph C. Galante by /s/ Michael Bonner as
attorney-in-fact
2019-09-20